Viral Vector
Manufacturing
We develop and manufacture viral vectors that meet clinical and commercial demands for gene therapy products
![Milan lab](https://www.agcbio.com/hs-fs/hubfs/CLEAN%20headers/Milan-lab-2.jpg?width=1920&height=1280&name=Milan-lab-2.jpg)
CDMO Viral Vector Services
With our full-service viral vector offering, we can develop, manufacture, and optimize lenti (LVV), retro (RVV), and adeno-associated (AAV) viral vectors.
Extensive Experience Through Commercial
Benefiting from over 25 years of industry-leading expertise and four commercially approved products, AGC Biologics is at the forefront of viral vector clinical and commercial manufacturing capabilities with substantial GMP capacity, approved by regulatory authorities.
![AGC_Milano_015-1](https://www.agcbio.com/hs-fs/hubfs/Website_Images/AGC_Milano_015-1.jpg?width=1200&height=800&name=AGC_Milano_015-1.jpg)
Fast & Scalable Vector Production
Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes. cGMP viral vector manufacturing for suspension-based processes provide up to 2,000 L. We also utilize iCELLis 500 bioreactor technology for adherent processes up to 200 L.
![AGC_Milano_025-1](https://www.agcbio.com/hs-fs/hubfs/Website_Images/AGC_Milano_025-1.jpg?width=1199&height=800&name=AGC_Milano_025-1.jpg)
Full Lifecycle Development Systems
Our quality systems, manufacturing scales, and regulatory expertise allow us to meet both clinical and commercial viral vector demands. Moreover, our scale-down capabilities provide flexible and cost-effective solutions for process development and pre-clinical studies.
![_MG_7894](https://www.agcbio.com/hs-fs/hubfs/Website_Images/_MG_7894.jpg?width=1000&height=667&name=_MG_7894.jpg)
Viral Vector Manufacturing Track Record
0
Years of experience
0
Commercial viral vector products
+0
Manufactured viral vector GMP batches
End-to-End Viral Vector Services
AGC Biologics scientists have three decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products.
Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. Our scale-down capabilities provide flexible and cost-effective solutions for process development and pre-clinical studies.
Our quality systems, manufacturing scales, and regulatory expertise allow us to meet both clinical and commercial viral vector demands.
Got a project? Let's talk.![AGC_laboratory_015](https://www.agcbio.com/hubfs/AGC_laboratory_015.jpg)
Our vector platforms that cut your timeline in half
End-to-end viral vector offerings give developers plug-and-play templates for the entire development and manufacturing process
Listen to Expert Interviews from Teams at Our Cell & Gene Center of Excellence in Milan and Longmont
![Building Standardized Viral Vector Platforms with Margherita Neri](https://www.agcbio.com/hubfs/Videos/Video%20cover%20images%20Milan%20Interviews%20-%20Margherita-min.png)
![Building Better Analytical Methods for ATMPs with Francesca Rossetti](https://www.agcbio.com/hubfs/Videos/Video%20cover%20images%20Milan%20Interviews%20-%20Francesca%20R-min.png)
![Navigating the Changing ATMP Market with Luca Alberici](https://www.agcbio.com/hubfs/Videos/Video%20cover%20images%20Milan%20Interviews%20-%20Luca-min.png)
![Creating New Standards for ATMP Manufacturing with Sabrina Cazzaniga](https://www.agcbio.com/hubfs/Videos/Video%20cover%20images%20Milan%20Interviews%20-%20Sabrina-min.png)
![Delivering a GMP Process for ATMPs with Francesca Bellintani](https://www.agcbio.com/hubfs/Videos/Video%20cover%20images%20Milan%20Interviews%20-%20Francesca%20B-min.png)
![Video cover images Milan Interviews - Giuliana-min](https://www.agcbio.com/hubfs/Videos/Video%20cover%20images%20Milan%20Interviews%20-%20Giuliana-min.png)
![Video cover images CO SME interviews - Meghan Nelson-1](https://www.agcbio.com/hubfs/Videos/Video%20cover%20images%20CO%20SME%20interviews%20-%20Meghan%20Nelson-1.jpg)
Click and drag video thumbnails to see more content.
Viral Vector Development from Clinical to Commercial
![DSC_4498-1-1](https://www.agcbio.com/hubfs/Website_Images/DSC_4498-1-1.jpg)
Adhesion and Suspension
Small, medium, and large-scale equipment for both adherent and suspension processes.
![_MG_7717-1](https://www.agcbio.com/hubfs/Website_Images/_MG_7717-1.jpg)
Plug-and-Play Platform
Plug-and-play platform for large-scale AAV and LVV manufacturing that can be adapted to virtually any program.
![AGC_Milano_023-1](https://www.agcbio.com/hubfs/Website_Images/AGC_Milano_023-1.jpg)
Process Development
Customizable upstream and downstream process development including feasibility studies for new processes with reagents and materials.
![www.agcbio.comhubfsAGC_laboratory_181-1](https://www.agcbio.com/hs-fs/hubfs/social-suggested-images/www.agcbio.comhubfsAGC_laboratory_181-1.jpg?width=600&height=400&name=www.agcbio.comhubfsAGC_laboratory_181-1.jpg)
Analytical Development
Over 160 in-house analytical tests utilizing state-of-the-art techniques to guarantee accurate and reliable characterization.
Optimizing Large-Scale AAV Manufacturing
Learn about independent, innovative processes for producing high-quality, high-productivity AAVs.
A Tailored Approach to Viral Vector Production
A custom platform offers scalable, off-the-shelf manufacturing to accelerate your timeline to GMP and save costs.
Download